Episode 174: Dr Rodney Rohde - From CLS to MLS: A Journey In Standardization And Advocacy
Listen now
Description
On this episode Dr Rodney Rohde discusses his involvement with the ASCP's Blueprint for Action to address workforce shortages in the laboratory. He highlights the efforts of various organizations to create solutions and improve the situation, emphasizing that the workforce challenges existed prior to COVID-19 but were exacerbated by the pandemic.  Dr. Rohde explains the importance of aligning titles and credentials across different organizations and programs to create a unified identity for medical laboratory scientists. Transitioning from various titles like CLS (Clinical Laboratory Scientist) to MLS (Medical Laboratory Scientist) can establish a clear and recognizable identity that reflects the rigorous education and critical role these professionals play in healthcare. The process of standardizing titles and credentials involves collaboration with professional organizations, regulatory bodies, and educational institutions. Dr. Rohde shares his journey of leading the effort to change the program name at Texas State University from CLS to MLS. This two-year process involved collecting data, engaging with faculty, alumni, and students, navigating institutional procedures, and obtaining approvals at various levels within the university. Links for this episode: Pathology 101 for Tissue Image Analysis  Health Podcast Network  LabVine Learning The ConfLab from LabVine Dress A Med scrubs   Workforce in the Shadow of Healthcare –An Update on the Survival Status of Laboratory Medicine and Public Health Facing Massive Labor Shortage, ASCP Committed to Expanding Medical Laboratory Workforce The Clinical Laboratory Workforce: Understanding the Challenges to Meeting Current and Future Needs Aligning Educational Program Titles to the Medical Laboratory Science Career   People of Pathology Podcast: Twitter Instagram
More Episodes
Jospeh Mossel co-founded Ibex in 2016. Since its inception, Ibex has remained committed to developing AI applications for clinical diagnostics. The company achieved its first milestone in 2018 by deploying its first algorithm for prostate cancer. This algorithm not only enhanced diagnostic...
Published 06/10/24
My guests today are Imogen Fitt from Signify Research and Nathan Buchbinder from Proscia.  We discuss emerging trends in pathology, including: The current technology with the most significant impact in the field of pathology has been artificial intelligence (AI). AI has stirred up imaginations...
Published 06/03/24
Published 06/03/24